PHSL President Ann Johnson and Specialist Danielle Wu contributed to the November/December 2024 edition of Pharmacy Technology & Management Review (PTMR). In their Viewpoints article, Ann and Danielle provide an overview of the proposed Medicare $2 Drug List model and discuss potential implications for both Medicare enrollees and pharmacies.

Click here to read the article “Is CMS’s Proposed $2 Drug List Model Another Hit to Pharmacies?”